Literature DB >> 9717307

Isolation of Escherichia coli O86:K61 producing cyto-lethal distending toxin from wild birds of the finch family.

G Foster1, H M Ross, T W Pennycott, G F Hopkins, I M McLaren.   

Abstract

Escherichia coli was recovered from selected tissues of 43 out of a total of 46 finches found dead in the Scottish Highlands during April-May of 1994 and 1995. The isolates did not ferment sorbitol, rhamnose, sucrose or melibiose; they belonged to serogroup O86:K61, produced cytolethal distending toxin (CLDT) and possessed the eae gene sequence. The consistent recovery of organisms producing CLDT and possessing the eae gene suggests that these organisms may have played a significant role in the finch mortalities.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9717307     DOI： 10.1046/j.1472-765x.1998.00359.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN： 0266-8254            Impact factor:   2.858


  13 in total

1.  Phenotypic and genotypic characterization of avian Escherichia coli O86:K61 isolates possessing a gamma-like intimin.

Authors:  R M La Ragione; I M McLaren; G Foster; W A Cooley; M J Woodward
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

2.  Hygiene at winter bird feeders in a southwestern Ontario city.

Authors:  J F Prescott; D B Hunter; G D Campbell
Journal:  Can Vet J       Date:  2000-09       Impact factor: 1.008

3.  Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2.

Authors:  O Marchès; J P Nougayrède; S Boullier; J Mainil; G Charlier; I Raymond; P Pohl; M Boury; J De Rycke; A Milon; E Oswald
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant.

Authors:  E Oswald; H Schmidt; S Morabito; H Karch; O Marchès; A Caprioli
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

5.  Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (Type IV).

Authors:  István Tóth; Fréderique Hérault; Lothar Beutin; Eric Oswald
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

Review 6.  The Evasive Enemy: Insights into the Virulence and Epidemiology of the Emerging Attaching and Effacing Pathogen Escherichia albertii.

Authors:  Shantanu Bhatt; Marisa Egan; Brian Critelli; Andrew Kouse; Daniel Kalman; Chirag Upreti
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

7.  Escherichia albertii in wild and domestic birds.

Authors:  J Lindsay Oaks; Thomas E Besser; Seth T Walk; David M Gordon; Kimberlee B Beckmen; Kathy A Burek; Gary J Haldorson; Dan S Bradway; Lindsey Ouellette; Fred R Rurangirwa; Margaret A Davis; Greg Dobbin; Thomas S Whittam
Journal:  Emerg Infect Dis       Date:  2010-04       Impact factor: 6.883

Review 8.  The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious Toxin.

Authors:  Monika D Scuron; Kathleen Boesze-Battaglia; Mensur Dlakić; Bruce J Shenker
Journal:  Front Cell Infect Microbiol       Date:  2016-12-05       Impact factor: 5.293

9.  A Survey for Escherichia coli Virulence Factors in Asymptomatic Free-Ranging Parrots.

Authors:  André Becker Saidenberg; Neiva Maria Robaldo Guedes; Gláucia Helena Fernandes Seixas; Mariangela da Costa Allgayer; Erica Pacífico de Assis; Luis Fabio Silveira; Priscilla Anne Melville; Nilson Roberti Benites
Journal:  ISRN Vet Sci       Date:  2012-07-10

10.  Molecular characterization of cytolethal distending toxin gene-positive Escherichia coli from healthy cattle and swine in Nara, Japan.

Authors:  Atsushi Hinenoya; Kensuke Shima; Masahiro Asakura; Kazuhiko Nishimura; Teizo Tsukamoto; Tadasuke Ooka; Tetsuya Hayashi; Thandavarayan Ramamurthy; Shah M Faruque; Shinji Yamasaki
Journal:  BMC Microbiol       Date:  2014-04-18       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.